Global Anti-itch Drugs Market Growth 2026-2032
The global Anti-itch Drugs market size is predicted to grow from US$ 3743 million in 2025 to US$ 5156 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.
An antipruritic ointment is a topical medication used to relieve itching (pruritus) of the skin. It works by reducing the sensation of itching and soothing the skin.
The market for anti-itch ointments is expected to grow steadily in the coming years due to several factors. First, the incidence of skin conditions that cause itchiness is increasing worldwide, largely due to environmental factors such as pollution and climate change. Additionally, an aging population is expected to drive demand for anti-itch ointments, as older adults are more likely to develop skin conditions that cause itchiness.
LP Information, Inc. (LPI) ' newest research report, the “Anti-itch Drugs Industry Forecast” looks at past sales and reviews total world Anti-itch Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-itch Drugs sales for 2026 through 2032. With Anti-itch Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-itch Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-itch Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-itch Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-itch Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-itch Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-itch Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-itch Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
An antipruritic ointment is a topical medication used to relieve itching (pruritus) of the skin. It works by reducing the sensation of itching and soothing the skin.
The market for anti-itch ointments is expected to grow steadily in the coming years due to several factors. First, the incidence of skin conditions that cause itchiness is increasing worldwide, largely due to environmental factors such as pollution and climate change. Additionally, an aging population is expected to drive demand for anti-itch ointments, as older adults are more likely to develop skin conditions that cause itchiness.
LP Information, Inc. (LPI) ' newest research report, the “Anti-itch Drugs Industry Forecast” looks at past sales and reviews total world Anti-itch Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-itch Drugs sales for 2026 through 2032. With Anti-itch Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-itch Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-itch Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-itch Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-itch Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-itch Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-itch Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-itch Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single Preparation
- Compound Ointment
- Hospital
- Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Bayer
- Sanofi
- Combe Incorporated
- CR SANJIU
- Lingrui
- Jinyao Pharma
- Dinuo Pharma
- Huapont
- Medimetriks Pharmaceuticals
- Taro Pharmaceutical
- Teva
- Sun Pharmaceutical
- Perrigo
- What is the 10-year outlook for the global Anti-itch Drugs market?
- What factors are driving Anti-itch Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Anti-itch Drugs market opportunities vary by end market size?
- How does Anti-itch Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-itch Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-itch Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-itch Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-itch Drugs Segment by Type
2.2.1 Single Preparation
2.2.2 Compound Ointment
2.2.3 Anti-itch Drugs Sales by Type
2.2.3.1 Global Anti-itch Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Anti-itch Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Anti-itch Drugs Sale Price by Type (2021-2026)
2.3 Anti-itch Drugs Segment by Application
2.3.1 Hospital
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Anti-itch Drugs Sales by Application
2.3.4.1 Global Anti-itch Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Anti-itch Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Anti-itch Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-itch Drugs Breakdown Data by Company
3.1.1 Global Anti-itch Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-itch Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-itch Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-itch Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-itch Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-itch Drugs Sale Price by Company
3.4 Key Manufacturers Anti-itch Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-itch Drugs Product Location Distribution
3.4.2 Players Anti-itch Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-ITCH DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-itch Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-itch Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-itch Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-itch Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-itch Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-itch Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-itch Drugs Sales Growth
4.4 APAC Anti-itch Drugs Sales Growth
4.5 Europe Anti-itch Drugs Sales Growth
4.6 Middle East & Africa Anti-itch Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-itch Drugs Sales by Country
5.1.1 Americas Anti-itch Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-itch Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-itch Drugs Sales by Type (2021-2026)
5.3 Americas Anti-itch Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-itch Drugs Sales by Region
6.1.1 APAC Anti-itch Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-itch Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-itch Drugs Sales by Type (2021-2026)
6.3 APAC Anti-itch Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-itch Drugs by Country
7.1.1 Europe Anti-itch Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-itch Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-itch Drugs Sales by Type (2021-2026)
7.3 Europe Anti-itch Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-itch Drugs by Country
8.1.1 Middle East & Africa Anti-itch Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-itch Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-itch Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-itch Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-itch Drugs
10.3 Manufacturing Process Analysis of Anti-itch Drugs
10.4 Industry Chain Structure of Anti-itch Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-itch Drugs Distributors
11.3 Anti-itch Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-ITCH DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-itch Drugs Market Size Forecast by Region
12.1.1 Global Anti-itch Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-itch Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-itch Drugs Forecast by Type (2027-2032)
12.7 Global Anti-itch Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Anti-itch Drugs Product Portfolios and Specifications
13.1.3 Johnson & Johnson Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Anti-itch Drugs Product Portfolios and Specifications
13.2.3 Bayer Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Anti-itch Drugs Product Portfolios and Specifications
13.3.3 Sanofi Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Combe Incorporated
13.4.1 Combe Incorporated Company Information
13.4.2 Combe Incorporated Anti-itch Drugs Product Portfolios and Specifications
13.4.3 Combe Incorporated Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Combe Incorporated Main Business Overview
13.4.5 Combe Incorporated Latest Developments
13.5 CR SANJIU
13.5.1 CR SANJIU Company Information
13.5.2 CR SANJIU Anti-itch Drugs Product Portfolios and Specifications
13.5.3 CR SANJIU Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CR SANJIU Main Business Overview
13.5.5 CR SANJIU Latest Developments
13.6 Lingrui
13.6.1 Lingrui Company Information
13.6.2 Lingrui Anti-itch Drugs Product Portfolios and Specifications
13.6.3 Lingrui Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lingrui Main Business Overview
13.6.5 Lingrui Latest Developments
13.7 Jinyao Pharma
13.7.1 Jinyao Pharma Company Information
13.7.2 Jinyao Pharma Anti-itch Drugs Product Portfolios and Specifications
13.7.3 Jinyao Pharma Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jinyao Pharma Main Business Overview
13.7.5 Jinyao Pharma Latest Developments
13.8 Dinuo Pharma
13.8.1 Dinuo Pharma Company Information
13.8.2 Dinuo Pharma Anti-itch Drugs Product Portfolios and Specifications
13.8.3 Dinuo Pharma Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Dinuo Pharma Main Business Overview
13.8.5 Dinuo Pharma Latest Developments
13.9 Huapont
13.9.1 Huapont Company Information
13.9.2 Huapont Anti-itch Drugs Product Portfolios and Specifications
13.9.3 Huapont Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Huapont Main Business Overview
13.9.5 Huapont Latest Developments
13.10 Medimetriks Pharmaceuticals
13.10.1 Medimetriks Pharmaceuticals Company Information
13.10.2 Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolios and Specifications
13.10.3 Medimetriks Pharmaceuticals Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Medimetriks Pharmaceuticals Main Business Overview
13.10.5 Medimetriks Pharmaceuticals Latest Developments
13.11 Taro Pharmaceutical
13.11.1 Taro Pharmaceutical Company Information
13.11.2 Taro Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
13.11.3 Taro Pharmaceutical Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Taro Pharmaceutical Main Business Overview
13.11.5 Taro Pharmaceutical Latest Developments
13.12 Teva
13.12.1 Teva Company Information
13.12.2 Teva Anti-itch Drugs Product Portfolios and Specifications
13.12.3 Teva Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Teva Main Business Overview
13.12.5 Teva Latest Developments
13.13 Sun Pharmaceutical
13.13.1 Sun Pharmaceutical Company Information
13.13.2 Sun Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
13.13.3 Sun Pharmaceutical Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sun Pharmaceutical Main Business Overview
13.13.5 Sun Pharmaceutical Latest Developments
13.14 Perrigo
13.14.1 Perrigo Company Information
13.14.2 Perrigo Anti-itch Drugs Product Portfolios and Specifications
13.14.3 Perrigo Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Perrigo Main Business Overview
13.14.5 Perrigo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-itch Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-itch Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-itch Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-itch Drugs Segment by Type
2.2.1 Single Preparation
2.2.2 Compound Ointment
2.2.3 Anti-itch Drugs Sales by Type
2.2.3.1 Global Anti-itch Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Anti-itch Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Anti-itch Drugs Sale Price by Type (2021-2026)
2.3 Anti-itch Drugs Segment by Application
2.3.1 Hospital
2.3.2 Pharmacy
2.3.3 Other
2.3.4 Anti-itch Drugs Sales by Application
2.3.4.1 Global Anti-itch Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Anti-itch Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Anti-itch Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-itch Drugs Breakdown Data by Company
3.1.1 Global Anti-itch Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-itch Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-itch Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-itch Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-itch Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-itch Drugs Sale Price by Company
3.4 Key Manufacturers Anti-itch Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-itch Drugs Product Location Distribution
3.4.2 Players Anti-itch Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-ITCH DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-itch Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-itch Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-itch Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-itch Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-itch Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-itch Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-itch Drugs Sales Growth
4.4 APAC Anti-itch Drugs Sales Growth
4.5 Europe Anti-itch Drugs Sales Growth
4.6 Middle East & Africa Anti-itch Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-itch Drugs Sales by Country
5.1.1 Americas Anti-itch Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-itch Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-itch Drugs Sales by Type (2021-2026)
5.3 Americas Anti-itch Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-itch Drugs Sales by Region
6.1.1 APAC Anti-itch Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-itch Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-itch Drugs Sales by Type (2021-2026)
6.3 APAC Anti-itch Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-itch Drugs by Country
7.1.1 Europe Anti-itch Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-itch Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-itch Drugs Sales by Type (2021-2026)
7.3 Europe Anti-itch Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-itch Drugs by Country
8.1.1 Middle East & Africa Anti-itch Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-itch Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-itch Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-itch Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-itch Drugs
10.3 Manufacturing Process Analysis of Anti-itch Drugs
10.4 Industry Chain Structure of Anti-itch Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-itch Drugs Distributors
11.3 Anti-itch Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-ITCH DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-itch Drugs Market Size Forecast by Region
12.1.1 Global Anti-itch Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-itch Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-itch Drugs Forecast by Type (2027-2032)
12.7 Global Anti-itch Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Anti-itch Drugs Product Portfolios and Specifications
13.1.3 Johnson & Johnson Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Anti-itch Drugs Product Portfolios and Specifications
13.2.3 Bayer Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Anti-itch Drugs Product Portfolios and Specifications
13.3.3 Sanofi Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Combe Incorporated
13.4.1 Combe Incorporated Company Information
13.4.2 Combe Incorporated Anti-itch Drugs Product Portfolios and Specifications
13.4.3 Combe Incorporated Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Combe Incorporated Main Business Overview
13.4.5 Combe Incorporated Latest Developments
13.5 CR SANJIU
13.5.1 CR SANJIU Company Information
13.5.2 CR SANJIU Anti-itch Drugs Product Portfolios and Specifications
13.5.3 CR SANJIU Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CR SANJIU Main Business Overview
13.5.5 CR SANJIU Latest Developments
13.6 Lingrui
13.6.1 Lingrui Company Information
13.6.2 Lingrui Anti-itch Drugs Product Portfolios and Specifications
13.6.3 Lingrui Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lingrui Main Business Overview
13.6.5 Lingrui Latest Developments
13.7 Jinyao Pharma
13.7.1 Jinyao Pharma Company Information
13.7.2 Jinyao Pharma Anti-itch Drugs Product Portfolios and Specifications
13.7.3 Jinyao Pharma Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jinyao Pharma Main Business Overview
13.7.5 Jinyao Pharma Latest Developments
13.8 Dinuo Pharma
13.8.1 Dinuo Pharma Company Information
13.8.2 Dinuo Pharma Anti-itch Drugs Product Portfolios and Specifications
13.8.3 Dinuo Pharma Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Dinuo Pharma Main Business Overview
13.8.5 Dinuo Pharma Latest Developments
13.9 Huapont
13.9.1 Huapont Company Information
13.9.2 Huapont Anti-itch Drugs Product Portfolios and Specifications
13.9.3 Huapont Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Huapont Main Business Overview
13.9.5 Huapont Latest Developments
13.10 Medimetriks Pharmaceuticals
13.10.1 Medimetriks Pharmaceuticals Company Information
13.10.2 Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolios and Specifications
13.10.3 Medimetriks Pharmaceuticals Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Medimetriks Pharmaceuticals Main Business Overview
13.10.5 Medimetriks Pharmaceuticals Latest Developments
13.11 Taro Pharmaceutical
13.11.1 Taro Pharmaceutical Company Information
13.11.2 Taro Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
13.11.3 Taro Pharmaceutical Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Taro Pharmaceutical Main Business Overview
13.11.5 Taro Pharmaceutical Latest Developments
13.12 Teva
13.12.1 Teva Company Information
13.12.2 Teva Anti-itch Drugs Product Portfolios and Specifications
13.12.3 Teva Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Teva Main Business Overview
13.12.5 Teva Latest Developments
13.13 Sun Pharmaceutical
13.13.1 Sun Pharmaceutical Company Information
13.13.2 Sun Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
13.13.3 Sun Pharmaceutical Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Sun Pharmaceutical Main Business Overview
13.13.5 Sun Pharmaceutical Latest Developments
13.14 Perrigo
13.14.1 Perrigo Company Information
13.14.2 Perrigo Anti-itch Drugs Product Portfolios and Specifications
13.14.3 Perrigo Anti-itch Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Perrigo Main Business Overview
13.14.5 Perrigo Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-itch Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-itch Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Preparation
Table 4. Major Players of Compound Ointment
Table 5. Global Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Anti-itch Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Anti-itch Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Anti-itch Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Anti-itch Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Anti-itch Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Anti-itch Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Anti-itch Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Anti-itch Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Anti-itch Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Anti-itch Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Anti-itch Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Anti-itch Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Anti-itch Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Anti-itch Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Anti-itch Drugs Producing Area Distribution and Sales Area
Table 21. Players Anti-itch Drugs Products Offered
Table 22. Anti-itch Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Anti-itch Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Anti-itch Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Anti-itch Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Anti-itch Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Anti-itch Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Anti-itch Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Anti-itch Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Anti-itch Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Anti-itch Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Anti-itch Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Anti-itch Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Anti-itch Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Anti-itch Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Anti-itch Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Anti-itch Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Anti-itch Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Anti-itch Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Anti-itch Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Anti-itch Drugs
Table 52. Key Market Challenges & Risks of Anti-itch Drugs
Table 53. Key Industry Trends of Anti-itch Drugs
Table 54. Anti-itch Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Anti-itch Drugs Distributors List
Table 57. Anti-itch Drugs Customer List
Table 58. Global Anti-itch Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Anti-itch Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Anti-itch Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Anti-itch Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Anti-itch Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Anti-itch Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Anti-itch Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Anti-itch Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Anti-itch Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Anti-itch Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Anti-itch Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Anti-itch Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Anti-itch Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Anti-itch Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Johnson & Johnson Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson & Johnson Anti-itch Drugs Product Portfolios and Specifications
Table 74. Johnson & Johnson Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Latest Developments
Table 77. Bayer Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Anti-itch Drugs Product Portfolios and Specifications
Table 79. Bayer Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. Sanofi Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Anti-itch Drugs Product Portfolios and Specifications
Table 84. Sanofi Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Combe Incorporated Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Combe Incorporated Anti-itch Drugs Product Portfolios and Specifications
Table 89. Combe Incorporated Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Combe Incorporated Main Business
Table 91. Combe Incorporated Latest Developments
Table 92. CR SANJIU Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. CR SANJIU Anti-itch Drugs Product Portfolios and Specifications
Table 94. CR SANJIU Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. CR SANJIU Main Business
Table 96. CR SANJIU Latest Developments
Table 97. Lingrui Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Lingrui Anti-itch Drugs Product Portfolios and Specifications
Table 99. Lingrui Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Lingrui Main Business
Table 101. Lingrui Latest Developments
Table 102. Jinyao Pharma Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Jinyao Pharma Anti-itch Drugs Product Portfolios and Specifications
Table 104. Jinyao Pharma Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Jinyao Pharma Main Business
Table 106. Jinyao Pharma Latest Developments
Table 107. Dinuo Pharma Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Dinuo Pharma Anti-itch Drugs Product Portfolios and Specifications
Table 109. Dinuo Pharma Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Dinuo Pharma Main Business
Table 111. Dinuo Pharma Latest Developments
Table 112. Huapont Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Huapont Anti-itch Drugs Product Portfolios and Specifications
Table 114. Huapont Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Huapont Main Business
Table 116. Huapont Latest Developments
Table 117. Medimetriks Pharmaceuticals Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolios and Specifications
Table 119. Medimetriks Pharmaceuticals Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Medimetriks Pharmaceuticals Main Business
Table 121. Medimetriks Pharmaceuticals Latest Developments
Table 122. Taro Pharmaceutical Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Taro Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
Table 124. Taro Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Taro Pharmaceutical Main Business
Table 126. Taro Pharmaceutical Latest Developments
Table 127. Teva Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Teva Anti-itch Drugs Product Portfolios and Specifications
Table 129. Teva Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Teva Main Business
Table 131. Teva Latest Developments
Table 132. Sun Pharmaceutical Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Sun Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
Table 134. Sun Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Sun Pharmaceutical Main Business
Table 136. Sun Pharmaceutical Latest Developments
Table 137. Perrigo Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Perrigo Anti-itch Drugs Product Portfolios and Specifications
Table 139. Perrigo Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Perrigo Main Business
Table 141. Perrigo Latest Developments
Table 1. Anti-itch Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-itch Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Preparation
Table 4. Major Players of Compound Ointment
Table 5. Global Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Anti-itch Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Anti-itch Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Anti-itch Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Anti-itch Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Anti-itch Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Anti-itch Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Anti-itch Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Anti-itch Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Anti-itch Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Anti-itch Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Anti-itch Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Anti-itch Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Anti-itch Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Anti-itch Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Anti-itch Drugs Producing Area Distribution and Sales Area
Table 21. Players Anti-itch Drugs Products Offered
Table 22. Anti-itch Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Anti-itch Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Anti-itch Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Anti-itch Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Anti-itch Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Anti-itch Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Anti-itch Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Anti-itch Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Anti-itch Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Anti-itch Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Anti-itch Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Anti-itch Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Anti-itch Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Anti-itch Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Anti-itch Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Anti-itch Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Anti-itch Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Anti-itch Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Anti-itch Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Anti-itch Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-itch Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Anti-itch Drugs
Table 52. Key Market Challenges & Risks of Anti-itch Drugs
Table 53. Key Industry Trends of Anti-itch Drugs
Table 54. Anti-itch Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Anti-itch Drugs Distributors List
Table 57. Anti-itch Drugs Customer List
Table 58. Global Anti-itch Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Anti-itch Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Anti-itch Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Anti-itch Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Anti-itch Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Anti-itch Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Anti-itch Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Anti-itch Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Anti-itch Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Anti-itch Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Anti-itch Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Anti-itch Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Anti-itch Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Anti-itch Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Johnson & Johnson Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson & Johnson Anti-itch Drugs Product Portfolios and Specifications
Table 74. Johnson & Johnson Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Latest Developments
Table 77. Bayer Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Anti-itch Drugs Product Portfolios and Specifications
Table 79. Bayer Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. Sanofi Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Anti-itch Drugs Product Portfolios and Specifications
Table 84. Sanofi Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Combe Incorporated Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Combe Incorporated Anti-itch Drugs Product Portfolios and Specifications
Table 89. Combe Incorporated Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Combe Incorporated Main Business
Table 91. Combe Incorporated Latest Developments
Table 92. CR SANJIU Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. CR SANJIU Anti-itch Drugs Product Portfolios and Specifications
Table 94. CR SANJIU Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. CR SANJIU Main Business
Table 96. CR SANJIU Latest Developments
Table 97. Lingrui Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Lingrui Anti-itch Drugs Product Portfolios and Specifications
Table 99. Lingrui Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Lingrui Main Business
Table 101. Lingrui Latest Developments
Table 102. Jinyao Pharma Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Jinyao Pharma Anti-itch Drugs Product Portfolios and Specifications
Table 104. Jinyao Pharma Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Jinyao Pharma Main Business
Table 106. Jinyao Pharma Latest Developments
Table 107. Dinuo Pharma Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Dinuo Pharma Anti-itch Drugs Product Portfolios and Specifications
Table 109. Dinuo Pharma Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Dinuo Pharma Main Business
Table 111. Dinuo Pharma Latest Developments
Table 112. Huapont Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Huapont Anti-itch Drugs Product Portfolios and Specifications
Table 114. Huapont Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Huapont Main Business
Table 116. Huapont Latest Developments
Table 117. Medimetriks Pharmaceuticals Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolios and Specifications
Table 119. Medimetriks Pharmaceuticals Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Medimetriks Pharmaceuticals Main Business
Table 121. Medimetriks Pharmaceuticals Latest Developments
Table 122. Taro Pharmaceutical Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Taro Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
Table 124. Taro Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Taro Pharmaceutical Main Business
Table 126. Taro Pharmaceutical Latest Developments
Table 127. Teva Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Teva Anti-itch Drugs Product Portfolios and Specifications
Table 129. Teva Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Teva Main Business
Table 131. Teva Latest Developments
Table 132. Sun Pharmaceutical Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Sun Pharmaceutical Anti-itch Drugs Product Portfolios and Specifications
Table 134. Sun Pharmaceutical Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Sun Pharmaceutical Main Business
Table 136. Sun Pharmaceutical Latest Developments
Table 137. Perrigo Basic Information, Anti-itch Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Perrigo Anti-itch Drugs Product Portfolios and Specifications
Table 139. Perrigo Anti-itch Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Perrigo Main Business
Table 141. Perrigo Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-itch Drugs
Figure 2. Anti-itch Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-itch Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-itch Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-itch Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-itch Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-itch Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Preparation
Figure 12. Product Picture of Compound Ointment
Figure 13. Global Anti-itch Drugs Sales Market Share by Type in 2026
Figure 14. Global Anti-itch Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Anti-itch Drugs Consumed in Hospital
Figure 16. Global Anti-itch Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. Anti-itch Drugs Consumed in Pharmacy
Figure 18. Global Anti-itch Drugs Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Anti-itch Drugs Consumed in Other
Figure 20. Global Anti-itch Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global Anti-itch Drugs Sale Market Share by Application (2025)
Figure 22. Global Anti-itch Drugs Revenue Market Share by Application in 2026
Figure 23. Anti-itch Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Anti-itch Drugs Sales Market Share by Company in 2026
Figure 25. Anti-itch Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Anti-itch Drugs Revenue Market Share by Company in 2026
Figure 27. Global Anti-itch Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Anti-itch Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Anti-itch Drugs Sales Market Share by Country in 2026
Figure 38. Americas Anti-itch Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Anti-itch Drugs Sales Market Share by Region in 2026
Figure 46. APAC Anti-itch Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Anti-itch Drugs Sales Market Share by Country in 2026
Figure 57. Europe Anti-itch Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Anti-itch Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Anti-itch Drugs in 2026
Figure 74. Manufacturing Process Analysis of Anti-itch Drugs
Figure 75. Industry Chain Structure of Anti-itch Drugs
Figure 76. Channels of Distribution
Figure 77. Global Anti-itch Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Anti-itch Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Anti-itch Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Anti-itch Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Anti-itch Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Anti-itch Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Anti-itch Drugs
Figure 2. Anti-itch Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-itch Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-itch Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-itch Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-itch Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-itch Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Preparation
Figure 12. Product Picture of Compound Ointment
Figure 13. Global Anti-itch Drugs Sales Market Share by Type in 2026
Figure 14. Global Anti-itch Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Anti-itch Drugs Consumed in Hospital
Figure 16. Global Anti-itch Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. Anti-itch Drugs Consumed in Pharmacy
Figure 18. Global Anti-itch Drugs Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Anti-itch Drugs Consumed in Other
Figure 20. Global Anti-itch Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global Anti-itch Drugs Sale Market Share by Application (2025)
Figure 22. Global Anti-itch Drugs Revenue Market Share by Application in 2026
Figure 23. Anti-itch Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Anti-itch Drugs Sales Market Share by Company in 2026
Figure 25. Anti-itch Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Anti-itch Drugs Revenue Market Share by Company in 2026
Figure 27. Global Anti-itch Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Anti-itch Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Anti-itch Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Anti-itch Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Anti-itch Drugs Sales Market Share by Country in 2026
Figure 38. Americas Anti-itch Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Anti-itch Drugs Sales Market Share by Region in 2026
Figure 46. APAC Anti-itch Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Anti-itch Drugs Sales Market Share by Country in 2026
Figure 57. Europe Anti-itch Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Anti-itch Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Anti-itch Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Anti-itch Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Anti-itch Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Anti-itch Drugs in 2026
Figure 74. Manufacturing Process Analysis of Anti-itch Drugs
Figure 75. Industry Chain Structure of Anti-itch Drugs
Figure 76. Channels of Distribution
Figure 77. Global Anti-itch Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Anti-itch Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Anti-itch Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Anti-itch Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Anti-itch Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Anti-itch Drugs Revenue Market Share Forecast by Application (2027-2032)
